Pierre Stephan
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
Journal: Bone marrow transplantation
Published: March 02, 2026
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
Journal: Bone marrow transplantation
Published: June 20, 2025
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
Journal: Bone marrow transplantation
Published: June 20, 2025
The NF-κB RelA transcription factor is not required for CD8+ T-cell function in acute viral infection and cancer.
Journal: Frontiers in immunology
Published: January 31, 2024
Deep phenotyping of nodal T-cell lymphomas reveals immune alterations and therapeutic targets.
Journal: Haematologica
Published: October 16, 2023
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 09, 2023
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer.
Journal: The Journal of experimental medicine
Published: August 01, 2023
A T cell-intrinsic function for NF-κB RelB in experimental autoimmune encephalomyelitis.
Journal: Scientific reports
Published: August 10, 2021
Transcriptional Control of Regulatory T Cells in Cancer: Toward Therapeutic Targeting?
Journal: Cancers
Published: October 09, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026